Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?

• Johannes Boltze,
• Koji Abe,
• Andrew N. Clarkson,
• Oliver Detante,
• Oliver Detante,
• Pedro M. Pimentel-Coelho,
• Pedro M. Pimentel-Coelho,
• Paulo H. Rosado-de-Castro,
• Paulo H. Rosado-de-Castro,
• Paulo H. Rosado-de-Castro,
• Miroslaw Janowski,
• Miroslaw Janowski

Affiliations

Johannes Boltze

School of Life Sciences, University of Warwick, Coventry, United Kingdom

Koji Abe

Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Andrew N. Clarkson

Department of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand

Oliver Detante

Stroke Unit, Neurology Department, Grenoble Hospital, Grenoble, France

Oliver Detante

Grenoble Institute of Neurosciences, Inserm U1216, Université Grenoble Alpes, Grenoble, France

Pedro M. Pimentel-Coelho

Instituto de Biofísica Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Pedro M. Pimentel-Coelho

Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil

Paulo H. Rosado-de-Castro

Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Paulo H. Rosado-de-Castro

Department of Radiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Paulo H. Rosado-de-Castro

0D'Or Institute for Research and Education, Rio de Janeiro, Brazil

Miroslaw Janowski

1Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, United States

Miroslaw Janowski

2NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland